Presentation Theater: Exploring Clinical Data for a New RA Treatment


  • Recognize treatment challenges of patients with moderate to severe RA
  • Review the efficacy and safety of RINVOQ across 5 phase 3 clinical trials, including a head-to-head trial with a leading RA therapy
  • Understanding the ability of RINVOQ to improve signs and symptoms and physical function, reduce pain, achieve remission, and inhibit further joint damage

Speaker: Iftikhar Chowdhry, MD

Presented by AbbVie.


Interest: Presentation Theater
Session Time Slot(s): 
Wednesday, October 30
11:45 AM - 12:45 PM
Hilton Anatole Dallas - Cortez B